|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in)operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash operating lease costs | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Loss on debt extinguishment | |||||
| Amortization of discount and debt issue costs | |||||
| Gain on remeasurement of contingent consideration | |||||
| Other, net | |||||
| Endowment of shares to LifeStance Health Foundation | |||||
| Change in operating assets and liabilities, net of businesses acquired: | |||||
| Patient accounts receivable, net | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued payroll expenses | |||||
| Operating lease liabilities | |||||
| Other accrued expenses | |||||
| Net cash provided by (used in) operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Purchases of property and equipment | |||||
| Acquisitions of businesses, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Proceeds from initial public offering, net of underwriters discounts and commissions and deferred offering costs | |||||
| Issuance of common units to new investors | |||||
| Proceeds from long-term debt, net of discount | |||||
| Payments of debt issue costs | |||||
| Payments of long-term debt | |||||
| Prepayment for debt paydown | |||||
| Payments of contingent consideration | |||||
| Taxes related to net share settlement of equity awards | |||||
| Net cash (used in) provided by financing activities | |||||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | |||||
| Cash and cash equivalents - beginning of period | |||||
| CASH AND CASH EQUIVALENTS – END OF PERIOD | |||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | |||||
| Cash paid for interest, net | |||||
| Cash paid for taxes, net of refunds | |||||
| SUPPLEMENTAL DISCLOSURES OF NON CASH INVESTING AND FINANCING ACTIVITIES | |||||
| Equipment financed through finance leases | |||||
| Contingent consideration incurred in acquisitions of businesses | |||||
| Acquisition of property and equipment included in liabilities | |||||
| Surrender of common stock | |||||
| Issuance of common units for acquisitions of businesses | |||||
| Taxes related to net share settlement of equity awards included in liabilities | |||||
Loading...